SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. It provides barriers from the interaction of biological assaults, including a new strain of coronavirus, influenza, allergens and other airborne pathogens with the nasal epithelial tissue. The company was founded by Tomer Izraeli in January 2005 and is headquartered in Raanana, Israel.

Polyrizon Ltd.

Polyrizon Ltd. Ordinary Shares

PLRZ is trending due to significant premarket gains and news regarding its nasal spray technology, sparking community discussion about potential resistance levels and whether to buy. The stock's volatility, low float, and association with Israeli stocks contribute to the intense speculation, with comparisons being drawn to similar high-flying stocks. Discussions also include potential dilution, short squeezes, and the stock's long-term viability.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending as investors discuss its potential as an AI automation play following Needham's rating update to Hold. Community members are debating the company's growth prospects, share buybacks, and potential for a short squeeze after earnings. Talk centers around agentic AI revenue and the stock's valuation relative to peers in the tech and robotics sectors.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake is trending after announcing a partnership with Palantir to integrate their AI platforms, with analysts suggesting the company is well-positioned to capitalize on AI demand. The community is discussing the potential impact of this partnership, particularly on Snowflake's data cloud and its competitive positioning against other cloud service providers. Despite a YTD surge, some are questioning the valuation and profitability.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending following its earnings report, with initial positive reactions tempered by concerns about future performance and AI disruption; the community is actively debating whether the company's growth justifies its valuation and if its AI strategy is strong enough. Some investors express skepticism, citing a lack of trust in leadership and concerns about the company's ability to adapt to the evolving tech landscape, while others remain optimistic about its long-term potential.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth ($USAR) is trending due to a newly announced supply agreement between its subsidiary, Less Common Metals, and Solvay and Arnold Magnetic Technologies to supply rare earth metals. The community is discussing the significance of this agreement for rare earth independence and potential government support, while also debating the stock's volatility and comparing it to competitors.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as investors discuss its expansion into Canada and the potential impact on revenue, along with its recent acquisition of YourBio Health. Community members are debating whether these developments will drive the stock price higher or if it will face continued pressure from short sellers. Some see the company as undervalued, while others express concern about its ability to break through resistance levels.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

Recent data regarding uniQure's Huntington's disease treatment, AMT-130, has driven considerable discussion, especially after the FDA communicated that current data may not be sufficient for a BLA submission. The community is debating the future of QURE with some concerned about management's decisions and transparency, while others remain optimistic about the drug's potential and possibility of a buyout, citing the significant unmet need for Huntington's treatments. Concerns are circulating around the possibility of further delays and the need for additional trials.

Dollar General Corp. engages in the operation of merchandise stores. Its offerings include food, snacks, health and beauty aids, cleaning supplies, basic apparel, housewares, and seasonal items. It sells brands including Clorox, Energizer, Procter & Gamble, Hanes, Coca-Cola, Mars, Unilever, Nestle, Kimberly-Clark, Kellogg's, General Mills, and PepsiCo. The company was founded by J. L. Turner and Hurley Calister Turner Sr. in 1939 and is headquartered in Goodlettsville, TN.

Dollar General Corp.

Dollar General's recent earnings beat and raised fiscal year guidance have sparked community discussion around the stock's potential. While some investors express frustration with its past performance compared to tech stocks, others point to its value proposition and resilience in a challenging economic environment, especially with strategic initiatives like store remodels and digital upgrades. Broader context includes commentary around consumer spending habits and how tariff impacts could level the playing field for discount retailers.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF ($DIA) is trending amid speculation about a potential Fed rate cut in December, fueled by dovish comments from Fed officials and recent economic data. Community members are debating whether this rally is sustainable or if it's a bull trap before a deeper correction, with some pointing to oversold conditions in tech and potential rotation into value stocks. Discussions also involve the impact of economic data, upcoming announcements, and technical analysis on the ETF's price movement.

UP Fintech Holding Ltd. is an online brokerage firm that focuses on global investors. It provides an online trading platform that enables investors to trade in equities and other financial instruments on multiple exchanges around the world. The firm offers products and services, as well as a user experience to customers through its mobile first strategy. The company was founded by Tian Hua Wu in June 2014 and is headquartered in Singapore.

UP Fintech Holding Ltd - ADR

UP Fintech ($TIGR) is trending due to strong Q3 earnings results, including record revenue and profit, driving optimism among investors. The community highlights the company's impressive growth in client assets and funded accounts. Discussions also involve its valuation compared to competitors and potential for future growth in the Asian markets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket

Ainos, Inc. (NASDAQ:AIMD) Short Interest Update

Ainos, Inc. (NASDAQ:AIMD  Get Free Report) was the target of a large drop in short interest in February. As of February 29th, there was short interest totalling 7,600 shares, a drop of 65.9...

Ainos Reports Full Year 2023 Financial Results

Strategic pivot towards VELDONA and AI-powered point-of-care testing to continue in 2024Advancing VELDONA drug candidates to Phase III clinical studiesExpanding market of AI Nose-powered VOC-sensing...

12 titres de soins de sant  en mouvement lors de la session du 08/03/2024

Gagnants
Le titre Psyence Biomedical (NASDAQ:PBM) a grimp vendredi de 146,36% 3,13 dollars lors de la session ordinaire.
L'action Ainos (NASDAQ:AIMD) a grimp de 88,36% 2,11 dollars.
Le titre...

12 titoli sanitari in movimento, sessione regolare del 08/03/2024

Titoli in rialzo
Il titolo Psyence Biomedical (NASDAQ:PBM) ha osservato un incremento del 140,94% a 3,06 dollari durante la sessione regolare di venerd .
Il titolo Ainos (NASDAQ:AIMD) ha avuto un...

12 titres de soins de sant  en mouvement lors de la session apr s-cl ture le 07/03/2024

Gagnants
Le titre Ainos (NASDAQ:AIMD) a grimp jeudi de 101,78% 2,26 dollars lors de la session after-market.
Le titre Immuron (NASDAQ:IMRN) a grimp de 36,26% 6,20 dollars.
L'action Talis...

12 acciones de salud en movimiento durante la preapertura del 04/03/2024

Acciones al alza
Quoin Pharmaceuticals (NASDAQ:QNRX) crecieron un 129,95% para establecerse en los 6,37 d lares durante la sesi n del pre-market del lunes.
Ainos (NASDAQ:AIMD) experimentaron un...

12 titres de soins de sant  en mouvement lors de la session apr s-cl ture le 01/03/2024

Gagnants
Le titre Ainos (NASDAQ:AIMD) a mont vendredi de 54,28% 1,62 dollars lors de la session after-market.
Le titre Aadi Bioscience (NASDAQ:AADI) a grimp de 27,60% 2,45 dollars.
Le titre...

Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms

Updated Chemistry, Manufacturing, and Controls and Stability Test fulfill Ainos' development objectivesResolving the identified deficiencies will accelerate the timeline for Ainos' other clinical...

Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7th

Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.comSAN DIEGO, Feb. 01, 2024 (GLOBE NEWSWIRE...

Ainos, Inc. (NASDAQ: AIMD) is a dual-platform AI and biotechnology company based in San Diego, California, pioneering the digitization of scent with its proprietary AI Nose platform and advancing immune therapeutics. Their AI Nose technology, powered by a breakthrough smell language model, enables machine olfaction for applications in industries such as semiconductor manufacturing, robotics, smart factories, senior care, and women’s health. The company is also developing VELDONA, a low-dose oral interferon alpha with clinical programs targeting rare, autoimmune, and infectious diseases for both humans and animals. With recent industrial deployments and recurring revenue contracts in Asia, Ainos aims to transform diagnostics, preventive medicine, and industrial monitoring through innovative SmellTech and biotech solutions.

Current Price	$2.42
Prev Close	$2.06
Open	$2.04
Dividend Yield	0.00%
50-Day Moving Average	$3.15
Beta	0.71
Avg. Volume	42,320.16
PE Ratio	-0.58

52-Week High	$5.00
52-Week Low	$1.78
Market Capitalization	$11.65M
EPS (Annual)	-$7.82
Price to Book	1.15
Revenue Per Employee	$471.11
Enterprise Value/EBITDA	N/A

AIMD
Ainos Inc

Feed

News

Sentiment

Fundamentals

Info

Latest AIMD News

AIMDAinos Inc